These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32189924)

  • 1. Scores of Child-Pugh Classification Impact Overall Survival After Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors.
    Tanaka O; Kojima T; Ohbora A; Makita C; Taniguchi T; Ono K; Matsuo M; Nagata Y
    J Clin Exp Hepatol; 2020; 10(2):101-105. PubMed ID: 32189924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy.
    Hasan S; Thai N; Uemura T; Kudithipudi V; Renz P; Abel S; Kirichenko AV
    World J Gastrointest Surg; 2017 Dec; 9(12):256-263. PubMed ID: 29359031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience.
    Hijazi H; Campeau MP; Roberge D; Donath D; Lapointe R; Vandenbroucke-Menu F; Taussky D; Boudam K; Chan G; Bujold A; Delouya G
    Cureus; 2016 Dec; 8(12):e935. PubMed ID: 28123916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Dose-Response Relationship of Stereotactic Body Radiotherapy for Abdominal Lymph Node Metastases from Hepatocellular Carcinoma.
    Wang Y; Li Q; Zhang L; Liu S; Zhu J; Yang Y; Liu M; Zhang Y; Xi M
    Oncologist; 2023 Jun; 28(6):e369-e378. PubMed ID: 37011232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.
    Jang WI; Kim MS; Bae SH; Cho CK; Yoo HJ; Seo YS; Kang JK; Kim SY; Lee DH; Han CJ; Kim J; Park SC; Kim SB; Cho EH; Kim YH
    Radiat Oncol; 2013 Oct; 8():250. PubMed ID: 24160944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of stereotactic body radiotherapy for clinical outcomes of patients with liver metastasis and hepatocellular carcinoma: A retrospective study.
    Liu C; Yi Q; Zhou X; Han X; Jiang R
    Oncol Lett; 2023 Jul; 26(1):305. PubMed ID: 37323818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E; Schultheiss M; Bettinger D; Maruschke L; Neeff HP; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
    Radiat Oncol; 2017 Jul; 12(1):116. PubMed ID: 28701219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis.
    Lee P; Ma Y; Zacharias I; Bozorgzadeh A; Wilson S; Foley K; Rava P; Masciocchi M; Ding L; Bledsoe J; Fitzgerald TJ; Sioshansi S
    Adv Radiat Oncol; 2020; 5(5):889-896. PubMed ID: 33083650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
    Lee KH; Yu JI; Park HC; Park SY; Shin JS; Shin EH; Cho S; Jung SH; Han YY; Lim DH
    Radiat Oncol J; 2018 Jun; 36(2):129-138. PubMed ID: 29983033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center.
    Chen LC; Lin HY; Lee MS; Chiou WY; Huang LW; Chew CH; Hsu FC; Hung SK
    Tzu Chi Med J; 2021; 33(4):380-387. PubMed ID: 34760635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma.
    Chiang CL; Chan MKH; Yeung CSY; Ho CHM; Lee FAS; Lee VWY; Wong FCS; Blanck O
    Strahlenther Onkol; 2019 Mar; 195(3):254-264. PubMed ID: 30413833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.
    Wang PM; Chung NN; Hsu WC; Chang FL; Jang CJ; Scorsetti M
    Rep Pract Oncol Radiother; 2015; 20(6):417-24. PubMed ID: 26696781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival.
    Hilal L; Reyngold M; Wu AJ; Araji A; Abou-Alfa GK; Jarnagin W; Harding JJ; Gambarin M; El Dika I; Brady P; Navilio J; Berry SL; Flynn J; Zhang Z; Tuli R; Zinovoy M; Romesser PB; Cuaron JJ; Crane CH; Hajj C
    J Gastrointest Oncol; 2021 Aug; 12(4):1743-1752. PubMed ID: 34532124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
    Qiu H; Moravan MJ; Milano MT; Usuki KY; Katz AW
    J Gastrointest Cancer; 2018 Dec; 49(4):463-469. PubMed ID: 28710606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion.
    Munoz-Schuffenegger P; Barry A; Atenafu EG; Kim J; Brierley J; Ringash J; Brade A; Dinniwell R; Wong RKS; Cho C; Kim TK; Sapisochin G; Dawson LA
    Radiother Oncol; 2021 Mar; 156():120-126. PubMed ID: 33285195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.